Cryoprotectants for red blood cells: Evaluate safety and effectiveness by in vitro measures
MedComm – Future Medicine · 2023-12 · 2 (4)
DOI: 10.1002/mef2.67 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm – Future Medicine, online erschienen am 06.12.2023. Verfasst von Yuying Hu und 6 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The transfusion of red blood cells (RBCs) is crucial in current medicinal research. The shelf‐life of donated RBCs preserved by the normal method is very short, limiting their clinical application. Cryopreservation is a reliable and effective technology for the long‐term storage of RBCs. During the process, ice formation will cause irreversible injuries to RBCs. Glycerol is used as a cryoprotectant (CPA) for RBCs to mitigate cryoinjuries. But it severely induces RBC hemolysis and deformation. This review introduces some biocompatible and effective CPAs used for RBC cryopreservation, outlining recent advances. Currently, there is no uniform standard to determine whether a CPA is suitable for RBCs. According to previous studies, we summarize for the first time comprehensive methods to evaluate the performance of CPAs by ensuring their safety and effectiveness. The safety of CPAs is defined as the degree of damage to RBCs, while the effectiveness is demonstrated by the properties of thawed RBCs, including membrane properties, protein activities, rheological properties, and metabolites levels. A novel CPA that is confirmed suitable for RBCs by these methods may be applied to other cells. We believe comprehensive methods can thoroughly evaluate the performance of CPAs and promote the development of transfusion therapy in clinic.
Zitieren
APA
Hu, Y., Liu, X., Ahmad, A., Chen, J., Chen, X., Zhang, W., & Tan, S. (2023). Cryoprotectants for red blood cells: Evaluate safety and effectiveness by in vitro measures. MedComm – Future Medicine, 2(4). https://doi.org/10.1002/mef2.67
Vancouver
Hu Y, Liu X, Ahmad A, Chen J, Chen X, Zhang W, et al. Cryoprotectants for red blood cells: Evaluate safety and effectiveness by in vitro measures. MedComm – Future Medicine. 2023;2(4). doi:10.1002/mef2.67
BibTeX
@article{Hu2023,
author = {Hu, Yuying and Liu, Xiangjian and Ahmad, AKhlaq and Chen, Jiangming and Chen, Xiaoxiao and Zhang, Wenqian and Tan, Songwen},
title = {Cryoprotectants for red blood cells: Evaluate safety and effectiveness by in vitro measures},
journal = {MedComm – Future Medicine},
year = {2023},
volume = {2},
number = {4},
doi = {10.1002/mef2.67}
}
EUVIMED